Effects of remifentanil on intracellular Ca2+ and its transients induced by electrical stimulation and caffeine in rat ventricular myocytes

Chinese Medical Journal

Volumn 122, Issue 12, 2009, Pages 1439-1443

  Zhang, Ye ^a   Irwin, Michael G ^b   Li, Rui ^a   Chen, Zhi Wu ^a   Wong, Tak Ming ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cytosolic calcium; Opioid receptor; Remifentanil; Ventricular myocyte

Indexed keywords

CAFFEINE; CALCIUM ION; REMIFENTANIL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTROSTIMULATION; HEART MUSCLE CELL; HEART VENTRICLE; MALE; NONHUMAN; RAT; SPECTROFLUOROMETRY;

ANIMALS; CAFFEINE; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; ELECTRIC STIMULATION; MALE; MYOCYTES, CARDIAC; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 68349097409     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.12.016     Document Type: Article

References (17)

1. Zhang Y, Chen ZW, Irwin MG, Wong TM. Remifentanil mimics cardioprotective effect of ischemic preconditioning via protein kinase C activation in open chest of rats. Acta Pharmacol Sin 2005; 26: 546-550.
2. Zhang Y, Irwin MG, Wong TM. Remifentanil preconditioning protects against ischemic injury in the intact rat heart. Anesthesiology 2004; 101: 918-923.
3. Zhang Y, Irwin MG, Wong TM, Chen M, Cao CM. Remifentanil preconditioning confers cardioprotection via cardiac kappa- and delta-opioid receptors. Anesthesiology 2005; 102: 371-378.
4. 2+ homeostasis in rat ventricular myocytes subjected to ischemic insults. J Pharmacol Exp Ther 2004; 310: 606-613.
5. Wu S, Li HY, Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ Res 1999; 84: 1388-1395.
6. Atcheson R, Lambert DG. Update on opioid receptors. Br J Anaesth 1994; 73: 132-134.
7. Burkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short-acting, mu-opioid. Anesth Analg 1996; 83: 646-651.
8. Unlugenc H, Itegin M, Ocal I, Ozalevli M, Guler T, Isik G. Remifentanil produces vasorelaxation in isolated rat thoracic aorta strips. Acta Anaesthesiol Scand 2003; 47: 65-69.
9. 2+ sensitivity by delta- and kappa-opioid agonists in intact guinea pig hearts. Anesth Analg 2003; 96: 733-739.
10. 2+sensitivity in intact guinea pig beating hearts. Anesth Analg 2001; 92: 602-608.
11. 2+-transients and intracellular pH in cultured cardiac myocytes. J Mol Cell Cardiol 1993; 25: 599-613.
12. 2+ transients and contraction in rat ventricular myocytes. Anesthesiology 1998; 89: 1532-1542.
13. 2+ and contraction in rat ventricular myocytes. Anesth Analg 2004; 98: 1013-1016.
14. James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF, Leighton HJ. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991; 259: 712-718.
15. Ventura C, Bastagli L, Bernardi P, Caldarera CM, Guarnieri C. Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim Biophys Acta 1989; 987: 69-74.
16. Krumins SA, Faden AI, Feuerstein G. Opiate binding in rat hearts: modulation of binding after hemorrhagic shock. Biochem Biophys Res Commun 1985; 127: 120-128.
17. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997; 86: 24-33.